Top Markets
Coin of the day
Renascience Inc. Renascience Inc.

Renascience Inc.

4889
Classement en actions #21014
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively... Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.
Prix de l'action
$8.49
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$117.03M
Changement (1 jour)
-4.82%
Changement (1 an)
-45.48%
Pays
JP
Échange Renascience Inc. (4889)

Catégorie

Historique du prix de l'action pour Renascience Inc. (4889)
Prix de clôture le plus élevé : $8.43 le 2026-08-01

Prix de clôture le plus bas : $7.05 le 2021-09-01
Historique du prix de l'action de Renascience Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 2.00%
2025 471.92%
2024 -36.21%
2023 18.40%
2022 -62.92%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH